Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-Severe Plaque Psoriasis”

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT02408159
What this trial is testing

Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy

Who this might be right for
Psoriasis
Innovaderm Research Inc. 3
Post-approval studies (Phase 4)Study completedNCT02400749
What this trial is testing

Apremilast in Palmo-Plantar Psoriasis

Who this might be right for
Palmo-plantar Psoriasis
Innovaderm Research Inc. 100
Testing effectiveness (Phase 2)Study completedNCT05375955
What this trial is testing

Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Who this might be right for
Atopic DermatitisPlaque Psoriasis
Pfizer 263
Early research (Phase 1)Study completedNCT02397382
What this trial is testing

Pharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 16
Testing effectiveness (Phase 2)Study completedNCT02131324
What this trial is testing

DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Promius Pharma, LLC 50
Not applicableEnded earlyNCT00402818
What this trial is testing

RESTORE: Raptiva® (Efalizumab) Evaluation of Safety and Treatment Optimization

Who this might be right for
Plaque Psoriasis
Merck KGaA, Darmstadt, Germany 294
Testing effectiveness (Phase 2)Study completedNCT05772520
What this trial is testing

The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Hangzhou Highlightll Pharmaceutical Co., Ltd 82
Large-scale testing (Phase 3)Active Not RecruitingNCT06550076
What this trial is testing

TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Takeda 2,099
Post-approval studies (Phase 4)Study completedNCT04306315
What this trial is testing

Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 385
Not applicableStudy completedNCT04398732
What this trial is testing

Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients

Who this might be right for
Plaque Psoriasis
Pfizer 486
Post-approval studies (Phase 4)UnknownNCT00707070
What this trial is testing

Combining Acitretin and Efalizumab in the Therapy of Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Universita di Verona 100
Testing effectiveness (Phase 2)Study completedNCT01045577
What this trial is testing

A Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AB Science 25
Not applicableStudy completedNCT00800982
What this trial is testing

Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
University of California, San Francisco 30
Testing effectiveness (Phase 2)Study completedNCT02785185
What this trial is testing

Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT07290569
What this trial is testing

Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Oruka Therapeutics, Inc. 160
Large-scale testing (Phase 3)Study completedNCT05637515
What this trial is testing

Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity

Who this might be right for
Moderate Chronic Plaque PsoriasisSevere Chronic Plaque Psoriasis
Biocon Biologics Inc. 374
Testing effectiveness (Phase 2)Temporarily pausedNCT04121143
What this trial is testing

A Clinical Study of SHR-1314 Injection in the Treatment of Moderate to Severe Plaque Psoriasis in Adults

Who this might be right for
Plaque Psoriasis
Jiangsu HengRui Medicine Co., Ltd. 120
Not applicableLooking for participantsNCT06701513
What this trial is testing

A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)

Who this might be right for
Psoriasis
Bristol-Myers Squibb 350
Large-scale testing (Phase 3)Study completedNCT00106834
What this trial is testing

The Safety and Efficacy of Infliximab in Patients With Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 378
Early research (Phase 1)Study completedNCT02993471
What this trial is testing

Ixekizumab in Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 28
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation